Form 4: IGM Biosciences CFO Misbah Tahir Sells Shares to Cover Tax Obligations

IGM Biosciences CFO Misbah Tahir sold shares of common stock on March 13 and 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Misbah Tahir, CFO of IGM Biosciences, sold shares of the company's common stock on March 13 and 14, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On March 13, 2024, 2,897 shares were sold at a weighted average price of $9.8752, resulting in 92,961 shares beneficially owned following the transaction.
• On March 14, 2024, 2,543 shares were sold at a weighted average price of $10.1705, resulting in 90,418 shares beneficially owned following the transaction.
• The transactions were executed in multiple trades at varying prices within specified ranges.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine disclosure related to insider trading activity and is common for executives who receive stock-based compensation.

Stakeholder Impact

• The sale of shares by the CFO could have a minor, temporary impact on the stock price.

Key Dates